Breaking News - The Fly

Open Search

UBX

Unity Biotechnology

$

()

Unity Biotechnology announces extension of Phase 2b ASPIRE study of UBX1325

UBX

4/23/2024 - 08:07am

Unity Biotechnology price target lowered by $2 at H.C. Wainwright, here's why

UBX

4/16/2024 - 06:35am

Unity Biotechnology reports Q4 EPS (28c), consensus (72c)

UBX

4/15/2024 - 07:02am

Unity Biotechnology announces new research on potential of Senolytics

UBX

2/6/2024 - 08:18am

Unity Biotechnology doses first patients in Phase 2 ASPIRE study of UBX1325

UBX

12/12/2023 - 08:08am

Unity Biotechnology files to sell 2.27M shares of common stock for holders

UBX

12/6/2023 - 17:29pm

Wedbush upgrades Unity Biotechnology to Outperform, raises price target to $4

UBX

11/16/2023 - 08:32am

Unity Biotechnology upgraded to Outperform from Neutral at Wedbush

UBX

11/16/2023 - 06:10am

Unity Biotechnology reports Q3 EPS ($1.05), consensus (93c)

UBX

11/13/2023 - 16:23pm

Unity Biotechnology announces exercise of warrants for $4.8M

UBX

11/10/2023 - 08:10am

Unity Biotechnology announces 48-week results from Phase 2 ENVISION study

UBX

9/27/2023 - 07:03am

Unity Biotechnology reports Q2 EPS (85c), consensus (86c)

UBX

8/8/2023 - 17:01pm

Unity Biotechnology downgraded to Neutral at Wedbush on limited cash runway

UBX

6/26/2023 - 06:51am

Unity Biotechnology downgraded to Neutral from Outperform at Wedbush

UBX

6/26/2023 - 06:33am

Unity Biotechnology announces design of Phase 2b ASPIRE trial

UBX

6/21/2023 - 07:14am